HeroinDetoxClinics.com, Fentanyl Claiming More and More Lives in Hartford, Connecticut
04 avr. 2018 05h45 HE
|
Heroin Detox Clinics
SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Heroin Detox Clinics sheds light on the drug epidemic with a recent post about Hartford CT. The opioid epidemic is a continuing, deadly, and growing...
Drug Rehabs In Ohio Needed For New Drug Overdose Statistics
14 févr. 2018 10h36 HE
|
TheRecover.com
SAN DIEGO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ohio has now moved from the 4th highest overdoses due to opioids to the 3rd highest in the country, According to the news site The Recover. The Ohio...
Fraser Institute News Release: Counterfeit pharmaceutical drugs put Canadian patients at risk
08 févr. 2018 05h00 HE
|
Fraser Institute
VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Counterfeit pharmaceutical drugs pose a real risk to Canadians because they are showing up in brick-and-mortar pharmacies, not just on...
Fraser Institute Media Advisory: How are Canadians at risk from counterfeit pharmaceuticals? New study coming Thursday, Feb. 8
07 févr. 2018 06h00 HE
|
Fraser Institute
VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- On Thursday, Feb. 8, the Fraser Institute will release a new study examining counterfeit pharmaceutical drugs. Pharmaceutical...
Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain
10 janv. 2018 17h02 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm,...
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
28 nov. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Issue Brief Explores the Many Facets of Opioid Abuse
14 sept. 2016 07h33 HE
|
The Center for Health Affairs
CLEVELAND, Sept. 14, 2016 (GLOBE NEWSWIRE) -- The Center for Health Affairs' August 2016 Issue Brief, A Growing Epidemic: Battling Opioid Abuse in Ohio, explores the many facets of the opioid abuse...
Initiation of Phase 3 Clinical Trial on the Patient-controlled Pain Management Drug "SyB P-1501"
13 juin 2016 01h18 HE
|
SymBio Pharmaceuticals Ltd
TOKYO, June 13, 2016 (GLOBE NEWSWIRE) -- SymBio Pharmaceuticals Limited (Headquarters: Tokyo, “SymBio”) announced today that the Phase 3 clinical trial on “SyB P-1501” – a drug for...